Susanna Tamman

Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., Oh M.D., Choe K.W.Bloodstream Infections Due to Extended-Spectrum Beta-Lactamase-Producing Escherichiacoli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, withSpecial Emphasis on Antimicrobial Therapy. Antimicrob. Chemother. 2004; 48: 4574-4581.Kang C.I., Kim S.H., Bang J.W., Kim H.B., Kim N.J., Kim E.C, Oh M.D., Choe K.W.Community-Aquired versus Nosocomial Klebsiella pneumoniae Bacteremia: ClinicalFeatures, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance. JKorean Med Sci 2006; 21: 816-822.Karki T. Ravimiresistentsus Eestis. Eesti Arst 2004Knothe H. et al. Transferable resistance to cefotaxime, cefoxitime, cefamandole andcefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcenscens. Infection1983;11:315-317Ko W.C., Paterson D.L., Sagnimeni A.J., Hansen D.S., Von Gottberg A., Mohapatra S.,Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K.P., McCormackJ.G., Yu V.L. Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differencesin Clinical Patterns. Emerg Infect Dis. 2002 Feb; 8(2): 160-166Lai Y.C., Yang S.L., Peng H.L., Chang H.Y. Identification of Genes Present Specifically ina Virulent Strain of Klebsiella pneumoniae. Infect Immun. 2000 Dec; 68: 7149-7151.Langstraat J, Bohse M, Clegg S. Type 3 Fimbrial Shaft (MrkA) of Klebsiella pneumoniae,but Not the Fimbrial Adhesin (MrkD), Facilitates Biofilm Formation. Infect Immun. 2001;69: 5805-5812Lavender H., Jagnow J.J., Clegg S. Klebsiella pneumoniae type 3 fimbria-mediatedimmunity to infection in the murine model of respiratory disease. Int J Med Microbiol. 2005Jun; 295(3):153-9.Leesik H., Ani Ü., Juhani A., Altraja A. Microbial pathogens of adult community-acquiredpneumonia in Southern Estonia. Medicina (Kaunas) 2006; 42(5): 384-394.Liu P.Y.F. et al. Survey of the prevalence of beta-lactamases amongst 1000 gram-negativebacilli isolated consecutively at the Royal London Hospital. J. Antimicrob. Chemother. 1992;30:429-447Liu P.Y.F., Tung J.C., Ke S.C., Chen S.L. Molecular epidemiology of extended-spectrumspectrum Beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital inTaiwan. J Clin Microbiol 1998; 36: 2759-2762.Lõivukene K., Sepp E., Adamson V., Kallandi Ü., Otter K., Mägi H., Parts A., Rõõm A.,Naaber P. Acinetobacter baumannii, Pseudomonas aeruginosa ja Klebsiella pneumoniaetähtsus ja antibiootikumitundlikkus Eesti haiglate intensiivravi osakondades. Eesti Arst 2004;83 (8)Lõivukene K. Kermes K., Sepp E., Adamson V., Mitt P., Kallandi Ü., Otter K.,Pirožkova L., Kolesnikova V., Rõõm A., Kamõnina N., Timmas T., Kirs K., Voiko R.,Nemtseva G., Mägi H., Jürna M., Päro K., Laaring Ü., Abel K., Rudenko S., IvanovaM., Männik R., Naaber P. Invasiivsete patogeenide struktuur ja antibiootikumitundlikkus:olukord Eestis 2004. Eesti Arst 2005; 84 (8): 520–526Olive D.M., Bean P. Principles and Applications of Methods for DNA-Based Typing ofMicrobial Organisms. J Clin microbiol 1999 Jun; 37(6): 1661-1669.Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H.,Mulazimoglu L., Trenholme G., Klugman K.P., Bonomo R.A., Rice L.B., WagenerM.M., McCormack J.G., Yu V.L. Antibiotic Therapy for Klebsiella pneumoniae Bacteremia33